Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exagen Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
XGN
Nasdaq
3840
www.exagen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exagen Inc.
Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
- Feb 5th, 2025 11:38 am
Exagen Inc. to Participate in Upcoming Investor Conferences
- Feb 4th, 2025 9:05 pm
US Penny Stocks To Watch In January 2025
- Jan 20th, 2025 5:09 pm
Exagen Gains 28%, Insider Trades Reap Benefit
- Jan 20th, 2025 11:40 am
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
- Jan 12th, 2025 5:00 pm
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISEĀ® CTD
- Dec 12th, 2024 2:00 pm
Data Storage And 2 Other US Penny Stocks To Watch
- Dec 10th, 2024 8:08 pm
Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- Nov 15th, 2024 10:50 am
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISEĀ® CTD Platform
- Nov 14th, 2024 9:30 pm
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
- Nov 13th, 2024 9:05 pm
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
- Nov 13th, 2024 7:09 am
Q3 2024 Exagen Inc Earnings Call
- Nov 13th, 2024 5:51 am
Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates
- Nov 12th, 2024 2:25 pm
November 2024 Penny Stocks On US Exchanges To Consider
- Nov 11th, 2024 8:08 pm
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
- Oct 29th, 2024 8:05 pm
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
- Oct 21st, 2024 8:05 pm
Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week
- Sep 13th, 2024 11:17 am
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
- Sep 4th, 2024 8:05 pm
Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now
- Aug 29th, 2024 1:55 pm
Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock
- Aug 26th, 2024 12:50 pm
Scroll